Powder: -20°C for 3 years | In solvent: -80°C for 2 years
Retagliptin is a DPP-4 inhibitor potentially used to treat Type 2 diabetes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | 6-8 weeks | Inquiry | |
100 mg | 6-8 weeks | Inquiry |
Description | Retagliptin is a DPP-4 inhibitor potentially used to treat Type 2 diabetes. |
Synonyms | SP-2086, SP2086, SP 2086 |
Molecular Weight | 464.368 |
Formula | C19H18F6N4O3 |
CAS No. | 1174122-54-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Retagliptin 1174122-54-3 SP-2086 SP2086 SP 2086 inhibitor inhibit